ArticleNature methods2026
A cloud-based miniscope for neurosurveillance of brain health and disease in freely behaving animals.
Article in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Miniaturized microscopes or 'miniscopes' for neuroimaging in freely behaving animals mostly operate over short durations (<2 h) and image either neuronal activity or cerebral hemodynamics. In contrast, central nervous system (CNS) disease models involving seizures, brain tumors etc. necessitate long-term (>24 h) imaging, remote operation and simultaneous characterization of multiple neurophysiological variables such as neuronal activity, blood flow, blood volume, oxygenation and cellular dynamics (a capability that we call 'neurosurveillance'). Thus, we developed the 'CloudScope', a cloud-based multicontrast miniscope for autonomous neurosurveillance in freely behaving animals. Its cloud-based architecture enables global remote operation and continuous acquisition of multicontrast images over CNS disease model life cycles. We demonstrate CloudScope's neurosurveillance capabilities in predicting behavior from 24-h neuroimaging data with deep learning (DL), characterizing neurovascular changes during natural behavior, seizure-induced neurovascular disruptions, and in vivo cellular and microvascular phenotyping of brain tumor microenvironments. Finally, CloudScope's architecture enables 'time-shared' imaging, which potentially reduces animal use. Collectively, CloudScope's neurosurveillance capabilities in conjunction with CNS disease models establish a new paradigm for characterizing their etiology and evolution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.